drugset
drugset / Trial / NCT02949999

Voclosporin in Healthy Japanese Volunteers

NCT02949999 ↗

Phase 1 Completed 40 enrolled Aurinia Pharmaceuticals Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is a single-centre, double-blind, placebo controlled, randomized, ascending multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamic profiles of voclosporin.

Timeline

Start
2016-10
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Voclosporin Other / unclassified 0.25 mg/kg Oral
Subject Voclosporin Other / unclassified 0.5 mg/kg Oral
Subject Voclosporin Other / unclassified 1 mg/kg Oral
Subject Voclosporin Other / unclassified 1.5 mg/kg Oral

Indications

No indication recorded.